Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19679479 | 0.92 | ALDH1A1 (0.37) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL24178615 | 0.92 | ALDH1A1 (0.37) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL20938176 | 0.91 | ALDH1A1 (0.37) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL23519330 | 0.88 | KDM4E (0.34) | ALDH1A1LMNAMAPK1KDM4EATM | |
| SCHEMBL17897504 | 0.87 | ALDH1A1 (0.40) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL19679488 | 0.87 | GABRG2 (0.34) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL23519378 | 0.86 | KDM4E (0.35) | ALDH1A1LMNAMAPK1KDM4EATM | |
| SCHEMBL27016146 | 0.86 | NR3C1 (0.33) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL20156161 | 0.86 | ALDH1A1 (0.41) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL27021422 | 0.86 | CYP1A2 (0.36) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11767324-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-09-26 | — | — | US | disclosed |
| US-20210179622-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | Research Business Foundation Sungkyunkwan University (KR) | 2021-06-17 | — | — | US | disclosed |
| WO-2019135633-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2019-07-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11767324-B2 | Compound and organic light-emitting device comprising same | CCNL2, DRD1, CCNA1 | ALDH1A1 61/4885LMNA 1085/4885HPGD 3767/4885 |
| US-20210179622-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CCNL2, CCNA1, DRD1 | ALDH1A1 58/4885LMNA 1682/4885HPGD 3746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.